What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring

Overview

Journal Diabetes Technol Ther

Specialties Endocrinology
Pharmacology

Date 2021 Apr 12

PMID 33844588

Citations 18

Authors

Rodolfo J Galindo

Christopher G Parkin

Grazia Aleppo

Anders L Carlson

Davida F Kruger

Carol J Levy

Guillermo E Umpierrez

Janet B McGill

Affiliations

Soon will be listed here.

Abstract

Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Medicaid Services (CMS) ignore conclusive evidence that supports CGM use in various diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the CMS eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.

Citing Articles

Expanding Access to Continuous Glucose Monitoring Through Empowering Primary Care: A Joint Endocrinology-Primary Care Quality Improvement Project.

Flint K, Fiore M, Justice A, Carney J, Colling C, Li J J Gen Intern Med. 2025; .

PMID: 40032724 DOI: 10.1007/s11606-025-09449-y.

Best practices and rationale for expanding Medicaid access to continuous glucose monitoring.

King C, Lilly A J Manag Care Spec Pharm. 2024; 30(10-b Suppl):S40-S49.

PMID: 39347971 PMC: 11443979. DOI: 10.18553/jmcp.2024.30.10-b.s40.

Innovation is the driver behind quality improvements in diabetes care delivery.

Hirsch I, Parkin C J Manag Care Spec Pharm. 2024; 30(10-b Suppl):S2-S6.

PMID: 39347969 PMC: 11443978. DOI: 10.18553/jmcp.2024.30.10-b.s2.

Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers.

Prahalad P, Hardison H, Odugbesan O, Lyons S, Alwazeer M, Neyman A Clin Diabetes. 2024; 42(1):27-33.

PMID: 38230344 PMC: 10788667. DOI: 10.2337/cd23-0052.

Assessment and prevention of hypoglycaemia in primary care among U.S. Veterans: a mixed methods study.

Pilla S, Meza K, Beach M, Long J, Gordon H, Bates J Lancet Reg Health Am. 2023; 28:100641.

PMID: 38076413 PMC: 10701452. DOI: 10.1016/j.lana.2023.100641.

References

Khunti K, Alsifri S, Aronson R, Cigrovski Berkovic M, Enters-Weijnen C, Forsen T . Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2017; 130:121-129. DOI: 10.1016/j.diabres.2017.05.004. View

Paris I, Henry C, Pirard F, Gerard A, Colin I . The new FreeStyle libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real-life conditions over a period of one year. Endocrinol Diabetes Metab. 2019; 1(3):e00023. PMC: 6354746. DOI: 10.1002/edm2.23. View

McGill J, Wu M, Pop-Busui R, Mizokami-Stout K, Tamborlane W, Aleppo G . Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network. J Diabetes Complications. 2019; 33(10):107400. DOI: 10.1016/j.jdiacomp.2019.06.005. View

Huynh P, Toulouse A, Hirsch I . ONE-YEAR TIME ANALYSIS IN AN ACADEMIC DIABETES CLINIC: QUANTIFYING OUR BURDEN. Endocr Pract. 2018; 24(5):489-491. DOI: 10.4158/EP-2017-0267. View

Majithia A, Kusiak C, Lee A, Colangelo F, Romanelli R, Robertson S . Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial. J Med Internet Res. 2020; 22(8):e21778. PMC: 7486672. DOI: 10.2196/21778. View

Bergenstal R, Layne J, Zisser H, Gabbay R, Barleen N, Lee A . Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic. Diabetes Technol Ther. 2020; 23(2):128-132. PMC: 7868574. DOI: 10.1089/dia.2020.0396. View

Tyndall V, Stimson R, Zammitt N, Ritchie S, McKnight J, Dover A . Marked improvement in HbA following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia. 2019; 62(8):1349-1356. PMC: 6647076. DOI: 10.1007/s00125-019-4894-1. View

Punthakee Z, Miller M, Launer L, Williamson J, Lazar R, Cukierman-Yaffee T . Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care. 2012; 35(4):787-93. PMC: 3308284. DOI: 10.2337/dc11-1855. View

Kovatchev B, Cox D, Gonder-Frederick L, Young-Hyman D, Schlundt D, Clarke W . Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care. 1998; 21(11):1870-5. DOI: 10.2337/diacare.21.11.1870. View

10.

Giorda C, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, Baccetti F . Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. Acta Diabetol. 2015; 52(5):845-53. DOI: 10.1007/s00592-015-0713-4. View

11.

Salehi S, Olyaeemanesh A, Mobinizadeh M, Nasli-Esfahani E, Riazi H . Assessment of remote patient monitoring (RPM) systems for patients with type 2 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord. 2020; 19(1):115-127. PMC: 7270436. DOI: 10.1007/s40200-019-00482-3. View

12.

Vigersky R, Fonda S, Chellappa M, Walker M, Ehrhardt N . Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2011; 35(1):32-8. PMC: 3241321. DOI: 10.2337/dc11-1438. View

13.

Weinstock R, DuBose S, Bergenstal R, Chaytor N, Peterson C, Olson B . Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes. Diabetes Care. 2015; 39(4):603-10. DOI: 10.2337/dc15-1426. View

14.

Peters A, Garg S . The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. Diabetes Technol Ther. 2020; 22(6):449-453. DOI: 10.1089/dia.2020.0187. View

15.

Bremer J, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B . Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009; 32(8):1513-7. PMC: 2713637. DOI: 10.2337/dc09-0114. View

16.

Polonsky W, Layne J, Parkin C, Kusiak C, Barleen N, Miller D . Impact of Participation in a Virtual Diabetes Clinic on Diabetes-Related Distress in Individuals With Type 2 Diabetes. Clin Diabetes. 2020; 38(4):357-362. PMC: 7566922. DOI: 10.2337/cd19-0105. View

17.

Charleer S, De Block C, Van Huffel L, Broos B, Fieuws S, Nobels F . Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Diabetes Care. 2019; 43(2):389-397. DOI: 10.2337/dc19-1610. View

18.

Van Beers C, DeVries J, Kleijer S, Smits M, Geelhoed-Duijvestijn P, Kramer M . Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016; 4(11):893-902. DOI: 10.1016/S2213-8587(16)30193-0. View

19.

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, Weitgasser R . Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016; 388(10057):2254-2263. DOI: 10.1016/S0140-6736(16)31535-5. View

20.

Gehlaut R, Dogbey G, Schwartz F, Marling C, Shubrook J . Hypoglycemia in Type 2 Diabetes--More Common Than You Think: A Continuous Glucose Monitoring Study. J Diabetes Sci Technol. 2015; 9(5):999-1005. PMC: 4667336. DOI: 10.1177/1932296815581052. View